U.S. House okays amendment on VA cannabis recommendations, Marijuana Herald says

The U.S. House of Representatives approved an amendment enabling Department of Veterans Affairs physicians to recommend medical cannabis to patients in states where it is legal, The Marijuana Herald’s Anthony Martinelli reports, citing the approval. The amendment, which is expected to get a final vote on the floor soon, stated,”None of the funds appropriated or otherwise made available to the Department of Veterans Affairs in this Act may be used to enforce Veterans Health Directive 1315 as it relates to: the policy stating that ‘VHA providers are prohibited from completing forms or registering Veterans for participation in a State-approved marijuana program’; the directive for the ‘Deputy Under Secretary for Health for Operations and Management’ to ensure that ‘medical facility Directors are aware that it is VHA policy for providers to assess Veteran use of marijuana but providers are prohibited from recommending, making referrals to or completing paperwork for Veteran participation in State marijuana programs’; and the directive for the ‘VA Medical Facility Director’ to ensure that ‘VA facility staff are aware of the following’ ‘(t)he prohibition recommending, making referrals to or completing forms and registering Veterans for participation in State-approved marijuana programs.” Publicly traded companies in the space include Aurora Cannabis (ACB), CV Sciences (CVSI), Canopy Growth (CGC), Cronos Group (CRON), Goodness Growth (GDNSF), Green Thumb Industries (GTBIF), IGC Pharma (IGC), Tilray (TLRY), Trees Corporation (CANN) and Trulieve Cannabis (TCNNF).